Health
Moffitt researchers discover regulatory pathway that blocks immune response against cancer – EurekAlert
In a new article published in the journal Immunity, Moffitt Cancer Center researchers show that TIM-3 inhibits the STING signaling pathway in dendritic cells, thereby…
TAMPA, Fla. – A hallmark of cancer is its ability to evade the immune system. It is why researchers are focused on finding new strategies and targets to jumpstart the immune system so it can mount a response against tumors. One such target is the inhibitory receptor T-cell immunoglobulin and mucin domain 3 (TIM-3), a protein that is overexpressed in many different types of cancer and is associated with poor patient outcomes. It is known to block the activity of immune cells, such as dendritic cells,…
-
Business23 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…
-
Noosa News22 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
General22 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News22 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland